News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,407 Results
Type
Article (40441)
Company Profile (264)
Press Release (654702)
Section
Business (205139)
Career Advice (2020)
Deals (35552)
Drug Delivery (91)
Drug Development (81214)
Employer Resources (169)
FDA (16151)
Job Trends (14869)
News (346416)
Policy (32589)
Tag
Academia (2588)
Alliances (49798)
Alzheimer's disease (1303)
Approvals (16121)
Artificial intelligence (182)
Bankruptcy (356)
Best Places to Work (11660)
Biotechnology (189)
Breast cancer (215)
Cancer (1598)
Cardiovascular disease (123)
Career advice (1682)
CAR-T (113)
Cell therapy (326)
Clinical research (65233)
Collaboration (613)
Compensation (314)
COVID-19 (2576)
C-suite (142)
Data (1513)
Diabetes (194)
Diagnostics (6317)
Earnings (85271)
Employer resources (146)
Events (111121)
Executive appointments (519)
FDA (16970)
Funding (550)
Gene therapy (226)
GLP-1 (643)
Government (4371)
Healthcare (18835)
Infectious disease (2674)
Inflammatory bowel disease (115)
Interviews (311)
IPO (16488)
Job creations (3643)
Job search strategy (1433)
Layoffs (436)
Legal (7897)
Lung cancer (238)
Manufacturing (224)
Medical device (13332)
Medtech (13337)
Mergers & acquisitions (19368)
Metabolic disorders (517)
Neuroscience (1685)
NextGen: Class of 2025 (6551)
Non-profit (4504)
Northern California (1926)
Obesity (295)
Opinion (195)
Patents (138)
People (57111)
Phase I (20349)
Phase II (28739)
Phase III (21393)
Pipeline (641)
Postmarket research (2564)
Preclinical (8607)
Radiopharmaceuticals (240)
Rare diseases (303)
Real estate (5931)
Regulatory (21918)
Research institute (2364)
Resumes & cover letters (352)
Southern California (1672)
Startups (3609)
United States (17309)
Vaccines (594)
Weight loss (204)
Date
Last 7 days (626)
Last 30 days (2596)
Last 365 days (34840)
2025 (2668)
2024 (35411)
2023 (40284)
2022 (51396)
2021 (55955)
2020 (54335)
2019 (46807)
2018 (35245)
2017 (32378)
2016 (31774)
2015 (37825)
2014 (31526)
2013 (26590)
2012 (28789)
2011 (29426)
2010 (27538)
Location
Africa (725)
Arizona (207)
Asia (37905)
Australia (6180)
California (4426)
Canada (1605)
China (371)
Colorado (199)
Connecticut (217)
Europe (81215)
Florida (633)
Georgia (154)
Illinois (434)
Indiana (249)
Maryland (699)
Massachusetts (3417)
Michigan (188)
Minnesota (323)
New Jersey (1245)
New York (1271)
North Carolina (811)
Northern California (1926)
Ohio (161)
Pennsylvania (1029)
South America (1102)
Southern California (1672)
Texas (644)
Utah (130)
Washington State (436)
695,407 Results for "c2i genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Veracyte Completes Acquisition of C2i Genomics
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform.
February 6, 2024
·
5 min read
Business
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform.
January 8, 2024
·
9 min read
Press Releases
Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)
January 14, 2025
·
5 min read
Press Releases
Ecotone Achieves Breakthrough in Human Genome Understanding with Novel AI Technology
AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases
January 16, 2025
·
1 min read
Press Releases
REVEAL GENOMICS® Links Immune Tumor Response to Longevity in Breast Cancer Survivors
January 13, 2025
·
7 min read
Press Releases
M42 signals genomics expansion with strategic partnership with Uzbekistan’s Ministry of Health on the Uzbek Genome Program
January 29, 2025
·
3 min read
Business
Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis
Children’s Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.
March 13, 2024
·
4 min read
healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
HUNTSVILLE, Ala., March 20, 2024 – healthŌme®, Inc., a leading genomics-based, precision health management company serving the life and critical illness industries, and GalenusRx, Inc.,
March 20, 2024
·
5 min read
Business
Dovetail Genomics and AGRF Announce Transformative Partnership Set to Advance Genomic Research in Australasia
Dovetail Genomics, a pioneering leader in the development of genomic solutions, announced a new strategic partnership with Australian Genome Research Facility.
June 24, 2024
·
4 min read
Press Releases
BostonGene to Participate in The Festival of Genomics & Biodata 2025
January 23, 2025
·
1 min read
1 of 69,541
Next